Medtronic

NYSE: MDT · Real-Time Price · USD
92.60
0.62 (0.67%)
At close: Aug 15, 2025, 9:58 AM

Medtronic Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Revenue
8.93B 8.29B 8.4B 7.92B 8.59B 8.09B 7.98B 7.7B 8.54B 7.73B 7.58B 7.37B 8.09B 7.76B 7.85B 7.99B 8.19B 7.78B 7.65B 6.51B
Cost of Revenue
3.15B 2.78B 2.95B 2.76B 3.04B 2.78B 2.76B 2.63B 2.98B 2.69B 2.54B 2.52B 2.59B 2.46B 2.5B 2.6B 2.65B 2.62B 2.71B 2.5B
Gross Profit
5.78B 5.51B 5.46B 5.15B 5.54B 5.31B 5.22B 5.07B 5.57B 5.04B 5.05B 4.86B 5.5B 5.3B 5.35B 5.39B 5.54B 5.15B 4.94B 4B
Operating Income
1.44B 1.65B 1.59B 1.28B 1.05B 1.48B 1.34B 1.27B 1.56B 1.39B 1.4B 1.13B 1.67B 1.66B 1.56B 859M 1.6B 1.28B 930M 673M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
1.26B 1.54B 1.56B 1.27B 856M 1.47B 1.31B 1.2B 1.55B 1.38B 1.4B 1.04B 1.6B 1.59B 1.49B 833M 1.57B 1.22B 525M 584M
Net Income
1.06B 1.29B 1.27B 1.04B 654M 1.32B 909M 791M 1.18B 1.22B 427M 929M 1.49B 1.48B 1.31B 763M 1.36B 1.27B 489M 487M
Selling & General & Admin
2.72B 2.72B 2.76B 2.65B 2.77B 2.67B 2.69B 2.61B 2.62B 2.62B 2.62B 2.57B 2.57B 2.56B 2.62B 2.55B 2.6B 2.54B 2.6B 2.42B
Research & Development
684M 675M 697M 676M 675M 695M 698M 668M 639M 688M 676M 692M 652M 657M 676M 750M 632M 601M 639M 621M
Other Expenses
940M 475M 408M 545M 1.05B 456M 499M 525M 744M 343M 353M 471M 606M 416M 496M 1.23B 703M 739M 773M 291M
Operating Expenses
4.34B 3.87B 3.86B 3.88B 4.49B 3.82B 3.88B 3.81B 4B 3.65B 3.65B 3.73B 3.83B 3.65B 3.79B 4.53B 3.93B 3.88B 4.01B 3.33B
Interest Expense
174M 179M 209M 167M 202M 188M 180M 148M 187M 167M 118M 164M 143M 137M 136M 137M 142M 143M 470M 171M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.49B 6.65B 6.81B 6.64B 7.54B 6.61B 6.64B 6.43B 6.98B 6.33B 6.18B 6.25B 6.42B 6.1B 6.28B 7.13B 6.58B 6.5B 6.72B 5.83B
Income Tax Expense
199M 237M 281M 220M 197M 135M 402M 400M 362M 146M 959M 112M 110M 106M 176M 64M 200M -59M 31M 93M
Shares Outstanding (Basic)
1.28B 1.28B 1.28B 1.29B 1.32B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.34B 1.34B 1.35B 1.34B 1.35B 1.35B 1.34B 1.34B
Shares Outstanding (Diluted)
1.29B 1.29B 1.29B 1.3B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.34B 1.35B 1.36B 1.36B 1.36B 1.36B 1.35B 1.35B
EPS (Basic)
0.82 1.01 0.99 0.81 0.49 0.99 0.68 0.59 0.89 0.92 0.32 0.70 1.11 1.10 0.97 0.57 1.01 0.94 0.36 0.36
EPS (Diluted)
0.82 1.01 0.99 0.80 0.49 0.99 0.68 0.59 0.88 0.92 0.32 0.70 1.10 1.10 0.97 0.56 1.00 0.94 0.36 0.36
EBITDA
2.27B 2.4B 2.44B 2.1B 1.71B 2.31B 2.17B 2.02B 2.42B 2.22B 2.18B 1.88B 2.43B 2.4B 2.31B 1.64B 2.39B 2.04B 1.67B 1.42B
EBIT
1.44B 1.72B 1.77B 1.44B 1.06B 1.66B 1.49B 1.34B 1.74B 1.54B 1.51B 1.21B 1.75B 1.73B 1.63B 970M 1.71B 1.36B 995M 755M
Depreciation & Amortization
840M 684M 675M 662M 654M 649M 672M 672M 679M 679M 671M 668M 688M 672M 676M 671M 684M 678M 671M 669M